Two Sigma Investments
DRUG

Two Sigma Investments’s Bright Minds Biosciences DRUG Stock Holding History

Two Sigma Investments’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,601
Closed -$203K – 4659
2025
Q4 		$203K Sell
2,601
-8,110
-76% -$542K ﹤0.01% 3759
2025
Q3 		$650K Buy
+10,711
New +$416K ﹤0.01% 2856
2022
Q4 		– Sell
-2,214
Closed -$14K – 2862
2022
Q3 		$14K Buy
+2,214
New +$14.4K ﹤0.01% 2397

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Two Sigma Investments's DRUG Position: Q1 2026 in Review

Two Sigma Investments sold out of Bright Minds Biosciences (DRUG) in Q1 2026, closing a stake of 2,601 shares — an estimated $203K sold.

Two Sigma Investments first reported a position in DRUG in Q3 2022 and held it in 3 quarters. The position peaked at $650K in Q3 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Two Sigma Investments reported no remaining Bright Minds Biosciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 2,601 Bright Minds Biosciences shares in Q1 2026, an estimated $203K.
  • Two Sigma Investments first reported a position in Bright Minds Biosciences in Q3 2022 and held it in 3 quarters.
  • Two Sigma Investments's Bright Minds Biosciences position peaked at $650K in Q3 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.